13G Filing: Great Point Partners and Foamix Pharmaceuticals Ltd (FOMX)

Page 2 of 10

Page 2 of 10 – SEC Filing

CUSIP
No.  M46135105
13G/A Page
2 of 9 Pages
1.

NAMES OF REPORTING PERSONS

Great Point Partners, LLC

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):

37-1475292

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) o
3. SEC USE ONLY
4.

CITIZENSHIP OR PLACE OF ORGANIZATION

USA

NUMBER OF SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
5.

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

4,781,708

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

4,781,708

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,781,708

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
(See Instructions)

o
11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

12.87%1

12.

TYPE OF REPORTING PERSON (See Instructions)

IA

1 Based on a total of 37,167,791
shares outstanding, as reported in the Issuer’s Form 20-F filed with the SEC on February 21, 2017.

Follow Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)

Page 2 of 10